Lunai Bioworks (NASDAQ: LNAI) Launches National Chemical Defense Consortium Targeting $400M-$1.2B U.S. Countermeasure Programs; 3-Year AI Antidote Development Model

Opening Bell: March 19, 2026

XRP Treasury Evernorth Files SEC Form S-4 for Nasdaq Listing

Is Citizens Financial Stock Outperforming the Nasdaq?

Getty Images Receives Notice from NYSE Regarding Continued Listing Standard

Wall St set to open lower as soaring oil prices, Fed caution rattle investors